# Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse AML

> **NCT01496547** · PHASE2 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 47 (actual)

## Conditions studied

- Acute Leukemia

## Interventions

- **DRUG:** intensive chemo - RIC preparation

## Key facts

- **NCT ID:** NCT01496547
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2018-02-28
- **Final completion:** 2018-06-30
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2019-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01496547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01496547, "Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse AML". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01496547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*